Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ravi

Showing results (251-260 of 263) with videos related to

Pageof 27
Sort By:
Diabetes, Obesity & Metabolism|November 6, 2018
Double-blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase-4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT-I StudyRonan Roussel, Santiago Duran-García, Yilong Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2022
Corifollitropin Alfa Combined With Human Chorionic Gonadotropin in Adolescent Boys With Hypogonadotropic HypogonadismR Ravi Shankar, Suneri Shah, Hee-Koung Joeng, et al.
Scientific Reports|March 29, 2025
Growth variability of farm grown teak in response to climatic and soil factors across three agroclimatic zones of Tamil Nadu, IndiaR Ashick Rajah, S Radhakrishnan, A Balasubramanian, et al.
Diabetes|March 17, 2018
Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 DiabetesSudha S Shankar, R Ravi Shankar, Lori A Mixson, et al.
Pediatric Diabetes|November 15, 2021
Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulinMuhammad Yazid Jalaludin, Asma Deeb, Philip Zeitler, et al.
Trials|December 5, 2009
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injuryHaleema Shakur, Peter Andrews, Toomas Asser, et al.
Pediatric Diabetes|November 15, 2021
A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetesR Ravi Shankar, Philip Zeitler, Asma Deeb, et al.
BMJ (Clinical Research Ed.)|July 25, 2013
Tranexamic acid in trauma: we need stronger global health policyJosé Caballero Alvarado, Yashbir Dewan, Hesham Fathy Elsayed, et al.
Journal of Obstetrics and Gynaecology of India|November 13, 2018
Single Nucleotide Polymorphism-Based Noninvasive Prenatal Testing: Experience in IndiaIshwar Chander Verma, Ratna Puri, Eswarachary Venkataswamy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumorsE Izumchenko, K Paz, D Ciznadija, et al.
Pageof 27

Showing results (251-260 of 263) with videos related to

Sort By:
Pageof 27
Diabetes, Obesity & Metabolism|November 6, 2018
Double-blind, randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase-4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT-I StudyRonan Roussel, Santiago Duran-García, Yilong Zhang, et al.
The Journal of Clinical Endocrinology and Metabolism|March 11, 2022
Corifollitropin Alfa Combined With Human Chorionic Gonadotropin in Adolescent Boys With Hypogonadotropic HypogonadismR Ravi Shankar, Suneri Shah, Hee-Koung Joeng, et al.
Scientific Reports|March 29, 2025
Growth variability of farm grown teak in response to climatic and soil factors across three agroclimatic zones of Tamil Nadu, IndiaR Ashick Rajah, S Radhakrishnan, A Balasubramanian, et al.
Diabetes|March 17, 2018
Native Oxyntomodulin Has Significant Glucoregulatory Effects Independent of Weight Loss in Obese Humans With and Without Type 2 DiabetesSudha S Shankar, R Ravi Shankar, Lori A Mixson, et al.
Pediatric Diabetes|November 15, 2021
Efficacy and safety of the addition of sitagliptin to treatment of youth with type 2 diabetes and inadequate glycemic control on metformin without or with insulinMuhammad Yazid Jalaludin, Asma Deeb, Philip Zeitler, et al.
Trials|December 5, 2009
The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injuryHaleema Shakur, Peter Andrews, Toomas Asser, et al.
Pediatric Diabetes|November 15, 2021
A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetesR Ravi Shankar, Philip Zeitler, Asma Deeb, et al.
BMJ (Clinical Research Ed.)|July 25, 2013
Tranexamic acid in trauma: we need stronger global health policyJosé Caballero Alvarado, Yashbir Dewan, Hesham Fathy Elsayed, et al.
Journal of Obstetrics and Gynaecology of India|November 13, 2018
Single Nucleotide Polymorphism-Based Noninvasive Prenatal Testing: Experience in IndiaIshwar Chander Verma, Ratna Puri, Eswarachary Venkataswamy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumorsE Izumchenko, K Paz, D Ciznadija, et al.
Pageof 27